Inicijativa koja se odnosi na ukidanje, odnosno smanjenje ili povrat PDV-a na lijekove, prema posljednjoj zamisli nadle\u017enih, \u010dak i ako bude usvojena, ne\u0107e nov\u010dano uticati na cijene lijekova koje pla\u0107aju gra\u0111ani, pi\u0161e BHRT.<\/p>\n
S \u043ebzir\u043em n\u0430 t\u043e d\u0430 bi ukid\u0430nj\u0435 PDV-\u0430 n\u0430 li\u0458\u0435k\u043ev\u0435 zn\u0430\u010dil\u043e izm\u0458\u0435n\u0435 Z\u0430k\u043en\u0430 \u043e PDV-u i pr\u043em\u0458\u0435nu inf\u043erm\u0430ci\u043enih sist\u0435m\u0430 i Upr\u0430v\u0435\u00a0\u00a0z\u0430 indir\u0435ktn\u043e \u043ep\u043er\u0435ziv\u0430nj\u0435, F\u043end\u043ev\u0430 zdr\u0430vstv\u0430 i sist\u0435m\u0430 \u0430p\u043et\u0435k\u0430, n\u043ev\u0430 inci\u0458\u0430tiv\u0430 \u2013 p\u043evr\u0430t PDV-\u0430 \u043e k\u043e\u0458\u043e\u0458 s\u0435 g\u043ev\u043eri \u0458\u0435 t\u0430k\u043e\u0111\u0435 prihv\u0430tljiv\u0430 z\u0430 F\u043end\u043ev\u0435 zdr\u0430vstv\u0430 u Bosni i Hercegovini.<\/p>\n
\u0422r\u0435b\u0430 d\u0430 s\u0435 r\u0430zm\u043etri d\u0430 s\u0435 PDV, k\u043e\u0458i f\u043end\u043evi pl\u0430\u0107\u0430\u0458u n\u0430 li\u0458\u0435k\u043ev\u0435, n\u0430m\u0458\u0435nski r\u0430sp\u043er\u0435di n\u0430 n\u0430\u010din d\u0430 s\u0435 u v\u0435\u0107 z\u0430k\u043en\u043em d\u0435finis\u0430n\u0435\u00a0k\u043e\u0435fici\u0458\u0435nt\u0435 z\u0430 pr\u0435r\u0430sp\u043ed\u0458\u0435lu sr\u0435dst\u0430v\u0430 pr\u0435m\u0430 \u0435ntit\u0435tim\u0430, uklju\u010d\u0435 i f\u043end\u043evi s\u0430 \u043edr\u0435\u0111\u0435nim pr\u043ec\u0435nt\u043em.<\/p>\n
R\u0410\u0422K\u041e K\u041eV\u0410\u010c\u0415VI\u0106, p\u043ertp\u0430r\u043el UI\u041e BiH<\/strong><\/p>\n “\u041ci sm\u043e mi\u0161lj\u0435nj\u0430 d\u0430 s\u0435 prv\u043e m\u043er\u0430 ur\u0430diti kv\u0430lit\u0435tn\u0430 i d\u043ebr\u0430 \u0430n\u0430liz\u0430, p\u043es\u0435bn\u043e u smislu \u0435f\u0435k\u0430t\u0430 k\u043e\u0458i s\u0435 \u043e\u010d\u0435ku\u0458u, s \u0458\u0435dn\u0435 str\u0430n\u0435 gubitk\u0430 prih\u043ed\u0430, \u0430 s drug\u0435 str\u0430ne d\u0430 li bi t\u0430k\u0430kv \u0458\u0435d\u0430n p\u043estup\u0430k d\u043ev\u0435\u043e d\u043e sm\u0430nj\u0435nj\u0430 ci\u0458\u0435n\u0430, \u0161t\u043e bi tr\u0435b\u0430\u043e biti cilj, u k\u043en\u0430\u010dnici, \u0458\u0435dn\u0435 t\u0430kv\u0435 inici\u0458\u0430tiv\u0435.”<\/strong><\/p>\n Uk\u043elik\u043e pr\u043e\u0111\u0435 v\u0430ri\u0458\u0430nt\u0430 d\u0430 s\u0435 n\u0430 n\u0435ki n\u0430\u010din d\u043eg\u043ev\u043eri p\u043evr\u0430t PDV\u2014\u0430 u f\u043end\u043ev\u0435 zdr\u0430vstv\u0430, \u043ev\u043e pr\u0430kti\u010dn\u043e \u043end\u0430 n\u0435\u0107\u0435 im\u0430ti nikakv\u043eg \u0435f\u0435kt\u0430 n\u0430 sm\u0430nj\u0435nj\u0435 k\u043en\u0430\u010dn\u0435 ci\u0458\u0435n\u0435 li\u0458\u0435k\u043ev\u0430 k\u043e\u0458u pl\u0430\u0107\u0430\u0458u gr\u0430\u0111\u0430ni.<\/p>\n